Intervention

Olodaterol

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 12 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

12 shown

Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDNCT07541378 · 2024-03-11

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusNCT03240575 · 2017-08-14

Cardiovascular Function in COPD PatientsNCT03055988 · 2017-03-29

Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsNCT02969317 · 2017-02-24

Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsNCT02853123 · 2016-09-22

Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDNCT02683109 · 2016-03-08

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®NCT01696058 · 2012-09-01

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®NCT01694771 · 2012-09-01

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsNCT01533922 · 2012-03-01

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.NCT01533935 · 2012-02-01

Japan Long-term Safety for Tiotropium Plus OlodaterolNCT01536262 · 2012-02-01

Olodaterol Bridging Study in AsthmaNCT01428622 · 2011-10-01

Common conditions

Pulmonary Disease, Chronic Obstructive10 Asthma1 COPD (Chronic Obstructive Pulmonary Disease)1

Leading sponsors

Boehringer Ingelheim 11 Medical University of Bialystok 1

Trial status mix

COMPLETED10

SUSPENDED1

WITHDRAWN1

Phase mix

PHASE35

PHASE44

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.